HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GeneLink lawsuit

This article was originally published in The Rose Sheet

Executive Summary

New Jersey federal court preliminary injunction prevents LAB21 from using confidential information from collaborative effort to test market a DNA face cream featuring GeneLink's Proprietary SNP profiling methodology, firm announces Dec. 3. LAB21 agreed to a consent order, which dismissed the action, but makes the injunction enforceable until March 24, 2008. Genelink filed the lawsuit against LAB21 in March 2002, and is "very pleased" with the outcome, the company says. Terms of the settlement will not be disclosed...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011730

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel